Skip to content

Transplantation of a scaffold-free tissue engineered construct (TEC) derived from autologous synovial mesenchymal stem cells for cartilage repair

Transplantation of a scaffold-free tissue engineered construct (TEC) derived from autologous synovial mesenchymal stem cells for cartilage repair - Transplantation of a scaffold-free tissue engineered construct (TEC) for cartilage repair

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008266
Enrollment
6
Registered
2012-07-01
Start date
2012-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic chondral injury of the knee joint

Interventions

Implantation of a scaffold-free tissue engineered construct (TEC) derived from autologus synovial mesenchymal stem cell (MSC) for cartilage repair.

Sponsors

Department of Orthopaedics, Osaka University Graduate School of Medicine
Lead Sponsor
Osaka University Hospital, Medical Center for Translational Research
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a symptomatic (including pain, catching, locking, or joint effusion) chondral or meniscal lesion of the knee which is clinically detectable by MRI.

Exclusion criteria

Exclusion criteria: Patients with 1) Active local infection 2) Serious complications including malignancies 3) Alchol or drung abuse 4) Rheumatoid arthritis, gout, or pseudo gout 5) Abnormal alignment of lower extremity 6) Patello-femoral instability 7) Diabetes 8) Renal failure which requires dialysis 9) Infectious disease (HIV, HBV, HCV, HTLV, syphilis) 10) Pregnancy 11) the medication of corticosteroids 12) participation in other clinical trials 13)Judged inappropriate with other reason by the project investigators.

Design outcomes

Primary

MeasureTime frame
<Adverse events> presense or absence, pattern, severity, incidence and retention time of adverse events

Secondary

MeasureTime frame
Periodical assesement of clnical symptoms, evaluatetion by MRI, histology, activity scales (Lyshom, Tegnar), and by overall subjective assessment score (Knee Injury and Osteoarthritis Outcome Score, KOOS). Arthoscopic assessment of repaired tissue using ICRS evaluation package.

Countries

Japan

Contacts

Public ContactNorimasa Nakamura

Osaka University Center for Advanced Medical Engineering and Infomatics

n-nakamura@ort.med.osaka-u.ac.jp06-6879-3552

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026